Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunometabolic Profiling of T Cells and Innate Lymphoid Cells Uncovers Therapeutic Targets to Enhance Immunotherapy in Head and Neck Cancer. | Cancer Immunol Res | 2026 | 42804348 | PubTator, text mining | PubMed |
| Spatial Treg niches and the therapeutic reprogramming of tumour tolerance in cancer. | Front Cell Dev Biol | 2026 | 42769030 | PubTator, text mining | PubMed |
| Molecular heterogeneity and clonal origin of CCR8+ effector regulatory T cells in human cancer. | Nat Commun | 2026 | 42764351 | PubTator, text mining | PubMed |
| Semi-Mechanistic Modeling of S-531011, a Humanized Anti-CCR8 Monoclonal Antibody, for Prediction of CCR8 Receptor Occupancy in Human Tumor Tissues. | CPT Pharmacometrics Syst Pharmacol | 2026 | 42689490 | PubTator, text mining | PubMed |
| Nonpathogenic SIV Infection in Sooty Mangabeys Is Characterized by a Lack of Activation and Expansion of Monocytes. | J Med Primatol | 2026 | 42596509 | PubTator, text mining | PubMed |
| Tape-strip transcriptomics identify immune signatures in cutaneous T-cell lymphoma distinct from benign inflammatory skin diseases. | J Allergy Clin Immunol | 2026 | 42567485 | PubTator, text mining | PubMed |
| Leukocyte-Rich Platelet-Rich Plasma (L-PRP) Promotes Rejuvenation of Senescent Fibroblasts and Dermal Remodeling via CCL1-CCR8 Signaling and PKM2 Modulation. | Int J Mol Sci | 2026 | 42511624 | PubTator, text mining | PubMed |
| Next-generation precision oncology in microsatellite stable colorectal cancer: integrated targeting beyond RAS and RAF. | ESMO Open | 2026 | 42462280 | PubTator, text mining | PubMed |
| BLIMP-1 and CD39 expression define human effector memory regulatory T cells in blood and recall responses to viruses. | Immunol Cell Biol | 2026 | 42448314 | PubTator, text mining | PubMed |
| Selective Depletion of Tumor-Infiltrating CD4+CCR8+ Tregs by AZ084, a Novel CCR8 Antagonist. | Cancer Sci | 2026 | 42437746 | PubTator, text mining | PubMed |
| CC chemokines in epithelial ovarian cancer: orchestrating the metastatic microenvironment and therapy resistance. | Mol Biol Rep | 2026 | 42377632 | PubTator, text mining | PubMed |
| Discovery of 1-(3-phenoxybenzyl)-4-(1-phenyl-1H-1,2,3-triazol-4-yl)piperidine analogues as potent and selective agonists of the human CC chemokine receptor 8. | Eur J Med Chem | 2026 | 42302662 | PubTator, text mining | PubMed |
| A shift towards a type I immune response in chronic atopic dermatitis favours an IL-15 dependent tissue resident memory cell niche. | J Dermatol Sci | 2026 | 42270466 | PubTator, text mining | PubMed |
| AGPAT family members act as potential predictive biomarkers and therapeutic targets in cervical cancer. | Discov Oncol | 2026 | 42262621 | PubTator, text mining | PubMed |
| Intratumoral Regulatory T-cell Ablation Mediates Tumor Control Systemically without Autoimmunity. | Cancer Res | 2026 | 42228092 | PubTator, text mining | PubMed |
| Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications. | Int J Mol Sci | 2026 | 42196608 | PubTator, text mining | PubMed |
| Interleukin-4-producing type 2 innate lymphoid cells in the lymph node promote proallergic Tfh13 cell differentiation. | Immunity | 2026 | 42161270 | PubTator, text mining | PubMed |
| From Normal Mucosa to Colorectal Cancer in Lynch Syndrome: Single-Cell Dissection of Cellular Heterogeneity and Communication Networks. | Front Biosci (Landmark Ed) | 2026 | 42052848 | PubTator, text mining | PubMed |
| Monocyte Chemokines Enhance Atherosclerotic Plaque Necrosis After Bacterial Kidney Infection. | FASEB J | 2026 | 41930659 | PubTator, text mining | PubMed |
| Regulatory T cells in axial spondyloarthritis. | Commun Biol | 2026 | 41917236 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers